Abstract
Transgenic mice containing novel oncogene HCCR-2 were generated to analyse the phenotype and to characterize the role of HCCR-2 in cellular events. Mice transgenic for HCCR-2 developed breast cancers and metastasis. The level of p53 in HCCR-2 transgenic mice was elevated in most tissues including breast, brain, heart, lung, liver, stomach, kidney, spleen, and lymph node. We examined whether stabilized p53 is functional in HCCR-2 transgenic mice. Defective induction of p53 responsive genes including p21WAF1, MDM2, and bax indicates that stabilized p53 in HCCR-2 transgenic mice exists in an inactive form. These results suggest that HCCR-2 represents an oncoprotein that is related to breast cancer development and regulation of the p53 tumor suppressor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H and Foekens JA . (1992). Cancer Res., 52, 1107–1113.
Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA and Minna JD . (1988). Mol. Cell. Biol., 8, 2668–2673.
Byrne JA, Tomasetto C, Garnier JM, Rouyer N, Mattei MG, Bellocq JP, Rio MC and Basset P . (1995). Cancer Res., 55, 2896–2903.
Deininger MW, Goldman JM, Lydon N and Melo JV . (1997). Blood, 90, 3691–3698.
Dickson C, Creer A and Fantl V . (2000). Oncogene, 19, 1097–1101.
Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M and Beach D . (1995). Science, 269, 1575–1577.
Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA and Ruddle FH . (1980). Proc. Natl. Acad. Sci. USA, 77, 7380–7384.
Kim J, Cha JH, Tisher CC and Madsen KM . (1996). Am. J. Physiol. Renal Physiol., 270, F575–F592.
Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang S-W, Ryoo ZY, Kim I-K, Namkoong SE and Kim JW . (2003). Oncogene, 22, 4679–4689.
Land H, Parada LF and Weinberg RA . (1983). Nature, 304, 596–602.
Miki T, Matsui T, Heidaran MA and Aaronson SA . (1989). Gene, 83, 137–146.
Nebert DW . (1991). Mutat. Res., 247, 267–281.
Nowell P . (1976). Science, 194, 23–28.
Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA and Staal GE . (1992). Cancer Res., 52, 4773–4778.
Proux V, Provot S, Felder-Schmittbuhl MP, Laugier D, Calothy G and Marx M . (1996). J. Biol. Chem., 271, 30790–30797.
Sambrook J, Fritsch EF and Maniatis T . (1989). Molecular Cloning: A Laboratory Manual, 2nd edn. Maniatis T (ed). Cold Spring Harbor Laboratory: New York.
Schuuring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ and Mooi WJ . (1992). Cancer Res., 52, 5229–5234.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF . (1989). Science, 244, 707–712.
Smith JB and Wickstrom E . (1998). J. Natl. Cancer Inst., 90, 1146–1154.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ko, J., Shin, S., Oh, Y. et al. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice. Oncogene 23, 1950–1953 (2004). https://doi.org/10.1038/sj.onc.1207356
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207356
Keywords
This article is cited by
-
Targeting HCCR expression resensitizes gastric cancer cells to chemotherapy via down-regulating the activation of STAT3
Scientific Reports (2016)
-
Silencing of the HCCR2 Gene Induces Apoptosis and Suppresses the Aggressive Phenotype of Hepatocellular Carcinoma Cells in Culture
Journal of Gastrointestinal Surgery (2011)
-
Transdifferentiation-inducing HCCR-1 oncogene
BMC Cell Biology (2010)
-
Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells
BMC Cancer (2010)
-
TCF/β-catenin plays an important role in HCCR-1 oncogene expression
BMC Molecular Biology (2009)